Episode Details

Kimball Electronics Q1 2026 earnings missed estimates, with revenue down 5.8% to $352.9M, adjusted EPS at $0.33, and EBITDA at $22.83M. The medical segment provided stability, but shares dropped 7.5% to $25.82, erasing $620M in market cap. Analysts questioned the new Indianapolis facilitys impact, capacity, and new medical customers. Executives remain optimistic about medical program ramps, automotive demand, and potential deals. Geopolitical risks and industrial trends pose potential disruptions, but the foundation appears solid.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/7aa0ff2e6c681d85